Literature DB >> 14707799

Does name-based HIV reporting deter high-risk persons from HIV testing? Results from San Francisco.

Sandra Schwarcz1, Jamila Stockman, Viva Delgado, Susan Scheer.   

Abstract

OBJECTIVE: Name-based HIV reporting has been recommended as a method to track the HIV epidemic but may deter or delay at-risk persons from HIV testing. Previous studies of a deterrent effect of HIV reporting were not conducted in areas with high HIV infection rates and politically active populations.
METHODS: In a cross-sectional survey, men who have sex with men (MSM) recruited from gay bars, heterosexuals recruited from the sexually transmitted disease clinic, and injection drug users (IDUs) recruited from street venues were administered a face-to-face anonymous questionnaire.
RESULTS: Ninety-four percent of the 118 MSM, 76% of the 99 heterosexuals, and 97% of 105 IDUs surveyed were tested. Six percent of MSM, 9% of heterosexuals, and none of the IDUs correctly identified California's HIV reporting regulations. Of the 75 (25%) participants who thought California had a name-based HIV reporting system, 2 were never tested and 23 had not been tested in the past 12 months. None of those who had never been tested and 2 of those who had not been tested in the past 12 months cited fear of being reported as a reason for not testing recently.
CONCLUSION: Fear of reporting is an infrequently cited reason for deterring or delaying testing.

Entities:  

Mesh:

Year:  2004        PMID: 14707799     DOI: 10.1097/00126334-200401010-00014

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  2 in total

1.  Who declines to give a name at a sexual health service?

Authors:  Heidi C Spillane; Anna M McNulty; Handan Wand; Kate Tribe; Basil Donovan
Journal:  Sex Transm Infect       Date:  2006-11-15       Impact factor: 3.519

2.  Engagement of African Americans with Rapid HIV Testing and HIV Care.

Authors:  Safiya George Dalmida; Graham J McDougall; George C T Mugoya; Pamela Payne Foster; Makenzie Plyman; Joe Burrage
Journal:  HIV/AIDS Res Treat       Date:  2017-09-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.